Jillian G. Johnson

920 total citations
26 papers, 669 citations indexed

About

Jillian G. Johnson is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jillian G. Johnson has authored 26 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Jillian G. Johnson's work include Drug Transport and Resistance Mechanisms (5 papers), Protist diversity and phylogeny (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Jillian G. Johnson is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Protist diversity and phylogeny (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Jillian G. Johnson collaborates with scholars based in United States, Japan and Australia. Jillian G. Johnson's co-authors include Frances M. Van Dolah, Jeanine S. Morey, Emily A. Monroe, Gary L. Hitchcock, Linda S. Wood, Andrew Rowland, Lauren A. Newman, Zivile Useckaite, Michael J. Sorich and Zhihong Wang and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Blood.

In The Last Decade

Jillian G. Johnson

25 papers receiving 657 citations

Peers

Jillian G. Johnson
Yuan H. Wen China
Daniel Knobeloch Germany
Barbara Zarzycka Netherlands
M Tatematsu Japan
Marion P. Boland United Kingdom
Timothy J. Waybright United States
Ryan M. Pelis United States
V. Venkat Rao United States
Myrtle A. Davis United States
Fabienne Meier‐Abt Switzerland
Yuan H. Wen China
Jillian G. Johnson
Citations per year, relative to Jillian G. Johnson Jillian G. Johnson (= 1×) peers Yuan H. Wen

Countries citing papers authored by Jillian G. Johnson

Since Specialization
Citations

This map shows the geographic impact of Jillian G. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jillian G. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jillian G. Johnson more than expected).

Fields of papers citing papers by Jillian G. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jillian G. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jillian G. Johnson. The network helps show where Jillian G. Johnson may publish in the future.

Co-authorship network of co-authors of Jillian G. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Jillian G. Johnson. A scholar is included among the top collaborators of Jillian G. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jillian G. Johnson. Jillian G. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hwang, Sunyoung, Jillian G. Johnson, Sara Martin, et al.. (2025). Sphingolipid synthesis maintains nuclear membrane integrity and genome stability during cell division. The Journal of Cell Biology. 224(8). 1 indexed citations
2.
Wang, X., Jillian G. Johnson, Linda S. Wood, et al.. (2024). Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib Exposure. Clinical Pharmacology in Drug Development. 13(10). 1098–1107. 1 indexed citations
3.
Li, Shufeng, Christine Huard, Shanrong Zhao, et al.. (2023). The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in Dermatomyositis. Arthritis & Rheumatology. 75(10). 1842–1849. 18 indexed citations
4.
Newman, Lauren A., Zivile Useckaite, Jillian G. Johnson, et al.. (2022). Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease. Biomedicines. 10(1). 195–195. 49 indexed citations
5.
Useckaite, Zivile, A. David Rodrigues, Ashley M. Hopkins, et al.. (2021). Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition. Drug Metabolism and Disposition. 49(11). 961–971. 15 indexed citations
6.
Rodrigues, A. David, Madelé van Dyk, Michael J. Sorich, et al.. (2021). Exploring the Use of Serum‐Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting Polypeptides. Clinical Pharmacology & Therapeutics. 110(1). 248–258. 44 indexed citations
7.
Kimoto, Emi, Lina Luo, Sumathy Mathialagan, et al.. (2020). Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 109(2). 507–516. 38 indexed citations
8.
Feng, Bo, Mark A. West, Nandini C. Patel, et al.. (2019). Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration. Journal of Pharmaceutical Sciences. 108(7). 2476–2483. 55 indexed citations
9.
Merchant, Akil, Catriona Jamieson, Michael Heuser, et al.. (2019). Abstract LB-009: Biomarkers correlating with overall survival (OS) and response to glasdegib and intensive or nonintensive chemotherapy in patients with acute myeloid leukemia (AML). Cancer Research. 79(13_Supplement). LB–9. 1 indexed citations
10.
Ratnayake, Anokha S., Mark E. Flanagan, Timothy L. Foley, et al.. (2019). A Solution Phase Platform to Characterize Chemical Reaction Compatibility with DNA-Encoded Chemical Library Synthesis. ACS Combinatorial Science. 21(10). 650–655. 39 indexed citations
11.
Mathialagan, Sumathy, Chester Costales, Laurie Tylaska, et al.. (2017). In vitrostudies with two human organic anion transporters: OAT2 and OAT7. Xenobiotica. 48(10). 1037–1049. 20 indexed citations
12.
Johnson, Jillian G., Louis E. Burnett, & Karen G. Burnett. (2016). Uncovering Hemocyanin Subunit Heterogeneity in Penaeid Shrimp using RNA-Seq. Integrative and Comparative Biology. 56(6). 1080–1091. 14 indexed citations
13.
Johnson, Jillian G., Michael G. Janech, & Frances M. Van Dolah. (2013). Caspase-like activity during aging and cell death in the toxic dinoflagellate Karenia brevis. Harmful Algae. 31. 41–53. 22 indexed citations
14.
Dolah, Frances M. Van, Mackenzie L. Zippay, Laura Pezzolesi, et al.. (2013). Subcellular localization of dinoflagellate polyketide synthases and fatty acid synthase activity. Journal of Phycology. 49(6). 1118–1127. 23 indexed citations
15.
Johnson, Jillian G., et al.. (2011). Transcriptome remodeling associated with chronological aging in the dinoflagellate, Karenia brevis. Marine Genomics. 5. 15–25. 27 indexed citations
16.
Morey, Jeanine S., et al.. (2011). Transcriptomic response of the red tide dinoflagellate, Karenia brevis, to nitrogen and phosphorus depletion and addition. BMC Genomics. 12(1). 346–346. 103 indexed citations
17.
Monroe, Emily A., et al.. (2010). CHARACTERIZATION AND EXPRESSION OF NUCLEAR‐ENCODED POLYKETIDE SYNTHASES IN THE BREVETOXIN‐PRODUCING DINOFLAGELLATE KARENIA BREVIS1. Journal of Phycology. 46(3). 541–552. 41 indexed citations
18.
Liston, Dane, Jonas B. Nielsen, Douglas S. Chapin, et al.. (1994). Syntheses and Anticholinesterase Activity of Tetrahydrobenzazepine Carbamates. Journal of Medicinal Chemistry. 37(13). 1996–2000. 12 indexed citations
19.
20.
Vinick, Fredric J., Nicholas A. Saccomano, B. Kenneth Koe, et al.. (1991). Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding. Journal of Medicinal Chemistry. 34(1). 86–89. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan H. Wen Breakdown of academic impact, for papers by Daniel Knobeloch Breakdown of academic impact, for papers by Barbara Zarzycka Breakdown of academic impact, for papers by M Tatematsu Breakdown of academic impact, for papers by Marion P. Boland Breakdown of academic impact, for papers by Timothy J. Waybright Breakdown of academic impact, for papers by Ryan M. Pelis Breakdown of academic impact, for papers by V. Venkat Rao Breakdown of academic impact, for papers by Myrtle A. Davis Breakdown of academic impact, for papers by Fabienne Meier‐Abt
Rankless by CCL
2026